{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T18:04:57Z","timestamp":1758823497435},"reference-count":10,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pediatric Surgery"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.jpedsurg.2008.03.062","type":"journal-article","created":{"date-parts":[[2008,9,10]],"date-time":"2008-09-10T13:19:59Z","timestamp":1221052799000},"page":"1630-1635","source":"Crossref","is-referenced-by-count":5,"title":["Is aggressive local treatment necessary for diffuse liver involvement in patients with progression of stage 4s neuroblastoma to stage 4?"],"prefix":"10.1016","volume":"43","author":[{"given":"Hugo A.","family":"Heij","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnauld C.","family":"Verschuur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gert-Jan L.","family":"Kaspers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rick R.","family":"van Rijn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judit A.","family":"Adam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel C.","family":"Aronson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpedsurg.2008.03.062_bib1","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/pbc.20564","article-title":"Liver involvement in neuroblastoma: the Memorial Sloan-Kettering experience supports treatment reduction in young patients","volume":"46","author":"Kushner","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpedsurg.2008.03.062_bib2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/pbc.20641","article-title":"Is liver metastasis in neuroblastoma an indication for treatment reduction","volume":"46","author":"Matthay","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpedsurg.2008.03.062_bib3","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/(SICI)1097-0142(19970901)80:5<834::AID-CNCR2>3.0.CO;2-L","article-title":"Neuroblastoma 4S. A heterogenous disease with variable risk factors and treatment strategies","volume":"80","author":"Noesel","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.jpedsurg.2008.03.062_bib4","article-title":"Long term outcomes in patients with stage 4S neuroblastoma","author":"Escobar","year":"2006"},{"key":"10.1016\/j.jpedsurg.2008.03.062_bib5","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/sj.bjc.6601154","article-title":"Treatment of stage 4S neuroblastoma\u2014a report of 10\u00a0years experience of the French Society of Paediatric Oncology","volume":"89","author":"Schleiermacher","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jpedsurg.2008.03.062_bib6","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/(SICI)1096-911X(199612)27:6<521::AID-MPO3>3.0.CO;2-N","article-title":"Hepatomegaly in neuroblastoma stage 4S: criteria for treatment of the vulnerable neonate","volume":"27","author":"Hsu","year":"1996","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.jpedsurg.2008.03.062_bib7","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/1096-911X(20001201)35:6<683::AID-MPO43>3.0.CO;2-F","article-title":"Metastatic neuroblastoma in infancy: what does the pattern of metastases contribute to prognosis","volume":"35","author":"Hero","year":"2000","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.jpedsurg.2008.03.062_bib8","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/pbc.20067","article-title":"4S neuroblastoma: the long term outcome","volume":"43","author":"Levitt","year":"2004","journal-title":"Pediatr Blood Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.jpedsurg.2008.03.062_bib9","first-page":"61","article-title":"131I-MIBG as first line treatment in advanced neuroblastoma","volume":"39","author":"Hoefnagel","year":"1995","journal-title":"Q J Nucl Med"},{"key":"10.1016\/j.jpedsurg.2008.03.062_bib10","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1053\/jpsu.2001.24002","article-title":"Late recurrence of neuroblastoma stage 4S with unusual clinicopathological findings","volume":"36","author":"Kato","year":"2001","journal-title":"J Pediatr Surg"}],"container-title":["Journal of Pediatric Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022346808003497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022346808003497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,25]],"date-time":"2018-12-25T19:51:06Z","timestamp":1545767466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022346808003497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0022346808003497"],"URL":"https:\/\/doi.org\/10.1016\/j.jpedsurg.2008.03.062","relation":{},"ISSN":["0022-3468"],"issn-type":[{"value":"0022-3468","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}